CIK 0001776111
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MBX Biosciences, Inc.
Sign in to watch- Ticker
- MBX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 317-989-3100
- Business address
- 11711 N. MERIDIAN STREET, SUITE 300, CARMEL, IN, 46032
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 7,693 shares at $5.89 ($45,312)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 190,672 shares at an average $10.60 ($2,020,756)
- 4 Open-market buy Director bought 190,672 shares at an average $10.60 ($2,020,756)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President & CEO bought 50,000 shares at $10.69 ($534,500)
- 4 Open-market buy Director bought 500,000 shares at $16.00 ($8,000,000)
- 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
- 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
- 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
- 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
- 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
- 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
- 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
- 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
- 4 Open-market buy Director bought 750,000 shares at $16.00 ($12,000,000)
- 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
Page 3 of 5 · 99 filings